Final answer:
Tepiratide, also known as Forteo, is a medication used for the treatment of osteoporosis. It is administered through daily subcutaneous injections and is indicated for postmenopausal women and men with a high risk of fractures. Treatment duration is limited to a maximum of two years.
Step-by-step explanation:
Tepiratide, also known as Forteo, is a medication used for the treatment of osteoporosis. It is a form of parathyroid hormone that helps to increase bone formation and prevent bone loss. One correct statement concerning tepiratide is that it is administered through daily subcutaneous injections.
Another correct statement is that tepiratide is specifically indicated for postmenopausal women and men with a high risk of fractures. It is not recommended for people with a history of bone cancer, radiation therapy, or Paget's disease of the bone.
Finally, tepiratide treatment duration is limited to a maximum of two years due to concerns about the potential risk of osteosarcoma, a type of bone cancer. After completing two years of treatment, alternative osteoporosis therapies should be considered.